These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 27044939)
1. Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030. Petrick JL; Kelly SP; Altekruse SF; McGlynn KA; Rosenberg PS J Clin Oncol; 2016 May; 34(15):1787-94. PubMed ID: 27044939 [TBL] [Abstract][Full Text] [Related]
2. Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States. Han SS; Kelly SP; Li Y; Yang B; Nguyen M; So S; Rosenberg PS; Hsing AW J Natl Cancer Inst; 2019 Jun; 111(6):550-556. PubMed ID: 30544184 [TBL] [Abstract][Full Text] [Related]
3. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805 [TBL] [Abstract][Full Text] [Related]
4. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention. Yang B; Liu JB; So SK; Han SS; Wang SS; Hertz A; Shariff-Marco S; Lin Gomez S; Rosenberg PS; Nguyen MH; Hsing AW Cancer; 2018 Sep; 124(17):3551-3559. PubMed ID: 30113700 [TBL] [Abstract][Full Text] [Related]
5. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis. Zhang X; El-Serag HB; Thrift AP Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):88-94. PubMed ID: 31712271 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. El-Serag HB; Lau M; Eschbach K; Davila J; Goodwin J Arch Intern Med; 2007 Oct; 167(18):1983-9. PubMed ID: 17923599 [TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. Altekruse SF; McGlynn KA; Reichman ME J Clin Oncol; 2009 Mar; 27(9):1485-91. PubMed ID: 19224838 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States. Rich NE; Yopp AC; Singal AG; Murphy CC Clin Gastroenterol Hepatol; 2020 Jan; 18(1):242-248.e5. PubMed ID: 31042582 [TBL] [Abstract][Full Text] [Related]
9. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States. Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481 [TBL] [Abstract][Full Text] [Related]
10. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. White DL; Thrift AP; Kanwal F; Davila J; El-Serag HB Gastroenterology; 2017 Mar; 152(4):812-820.e5. PubMed ID: 27889576 [TBL] [Abstract][Full Text] [Related]
11. Geographic variation within the United States in the incidence of hepatocellular carcinoma. Davila JA; Petersena NJ; Nelson HA; El-Serag HB J Clin Epidemiol; 2003 May; 56(5):487-93. PubMed ID: 12812824 [TBL] [Abstract][Full Text] [Related]
12. Disparities in Hepatocellular Carcinoma Incidence in California: An Update. Sangaramoorthy M; Yang J; DeRouen MC; Ho C; Somsouk M; Tana MM; Thompson CA; Gibbons J; Gomez SL; Shariff-Marco S Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):79-87. PubMed ID: 31719066 [TBL] [Abstract][Full Text] [Related]
13. Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018. Alvarez CS; Petrick JL; Parisi D; McMahon BJ; Graubard BI; McGlynn KA Hepatology; 2022 Sep; 76(3):589-598. PubMed ID: 35124828 [TBL] [Abstract][Full Text] [Related]
14. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study. Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301 [TBL] [Abstract][Full Text] [Related]
15. Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA. Beal EW; Tumin D; Kabir A; Moris D; Zhang XF; Chakedis J; Washburn K; Black S; Schmidt CM; Pawlik TM World J Surg; 2018 Mar; 42(3):835-840. PubMed ID: 28879603 [TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma: recent trends in the United States. El-Serag HB Gastroenterology; 2004 Nov; 127(5 Suppl 1):S27-34. PubMed ID: 15508094 [TBL] [Abstract][Full Text] [Related]
17. State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States. Lee YT; Wang JJ; Luu M; Tseng HR; Rich NE; Lu SC; Nissen NN; Noureddin M; Singal AG; Yang JD Hepatology; 2021 Sep; 74(3):1384-1394. PubMed ID: 33728665 [TBL] [Abstract][Full Text] [Related]
18. Decreasing incidence of hepatocellular carcinoma among most racial groups: SEER-22, 2000-2019. O'Brien TR; Devesa SS; Koshiol J; Marrero JA; Shiels MS Cancer Med; 2023 Oct; 12(19):19960-19967. PubMed ID: 37776201 [TBL] [Abstract][Full Text] [Related]
19. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort. Setiawan VW; Wei PC; Hernandez BY; Lu SC; Monroe KR; Le Marchand L; Yuan JM Cancer; 2016 May; 122(9):1444-52. PubMed ID: 26916271 [TBL] [Abstract][Full Text] [Related]
20. Socioeconomic status and hepatocellular carcinoma in the United States. Shebl FM; Capo-Ramos DE; Graubard BI; McGlynn KA; Altekruse SF Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1330-5. PubMed ID: 22669949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]